Delivery Order SPE2DB20D3101-SPE2DB25FRFV2
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,603.51, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 6, 2025. The contract is not designated with any set-aside requirements, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,254.40 for the provision of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of November 16, 2023 and is a Firm Fixed Price arrangement. This award is a part of AmerisourceBergen's broader Indefinite Delivery Contract...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,912.99, is for the delivery of 4567626817 VALSARTAN-HCTZ 320-25 MG TAB 90S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,133.66 firm fixed-price contract is for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication, to support military healthcare programs. The contract has a completion date of June 4, 2024 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,408.14, is a Delivery Order for the supply of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024, and is a Firm Fixed Price contract. This award is not associated with a set-aside program. In addition to this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,369.93, is for the delivery of Valsartan-HCTZ 320-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through June 6, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,351.98 firm fixed-price delivery order contract is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,493.49, is for the delivery of VALSARTAN-HCTZ 160-12.5 MG tablets in 90-count packages. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,101.61 Firm Fixed Price delivery order is for the supply of 4568160926 - VALSARTAN-HCTZ 320-25 MG TAB 90S, with a performance period through May 7, 2025. The contract is not set aside and was awarded on May 6, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,917.88, is for the delivery of valsartan-HCTZ 160-12.5 mg tablets over the period from April 2025 to April 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...